1. Home
  2. DHC vs CRGX Comparison

DHC vs CRGX Comparison

Compare DHC & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHC
  • CRGX
  • Stock Information
  • Founded
  • DHC 1998
  • CRGX 2021
  • Country
  • DHC United States
  • CRGX United States
  • Employees
  • DHC N/A
  • CRGX N/A
  • Industry
  • DHC Real Estate Investment Trusts
  • CRGX
  • Sector
  • DHC Real Estate
  • CRGX
  • Exchange
  • DHC Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • DHC 629.7M
  • CRGX 621.4M
  • IPO Year
  • DHC N/A
  • CRGX 2023
  • Fundamental
  • Price
  • DHC $2.07
  • CRGX $12.68
  • Analyst Decision
  • DHC Hold
  • CRGX Strong Buy
  • Analyst Count
  • DHC 3
  • CRGX 6
  • Target Price
  • DHC $4.50
  • CRGX $31.80
  • AVG Volume (30 Days)
  • DHC 1.1M
  • CRGX 279.0K
  • Earning Date
  • DHC 02-24-2025
  • CRGX 11-12-2024
  • Dividend Yield
  • DHC 1.91%
  • CRGX N/A
  • EPS Growth
  • DHC N/A
  • CRGX N/A
  • EPS
  • DHC N/A
  • CRGX N/A
  • Revenue
  • DHC $1,477,343,000.00
  • CRGX N/A
  • Revenue This Year
  • DHC N/A
  • CRGX N/A
  • Revenue Next Year
  • DHC $4.46
  • CRGX N/A
  • P/E Ratio
  • DHC N/A
  • CRGX N/A
  • Revenue Growth
  • DHC 6.62
  • CRGX N/A
  • 52 Week Low
  • DHC $2.01
  • CRGX $10.91
  • 52 Week High
  • DHC $4.24
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • DHC 36.83
  • CRGX 42.38
  • Support Level
  • DHC $2.02
  • CRGX $10.91
  • Resistance Level
  • DHC $2.14
  • CRGX $13.10
  • Average True Range (ATR)
  • DHC 0.09
  • CRGX 1.11
  • MACD
  • DHC 0.01
  • CRGX 0.02
  • Stochastic Oscillator
  • DHC 25.68
  • CRGX 38.21

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: